Skilled Sales/Use and Property Tax expert with strong work ethic and sense of ownership needed to excel in a government-regulated environment. Successful at managing multiple projects and consistently meeting deadlines under pressure. Extensive knowledge of accounting software and processes. Well-versed in supplying quick responses to financial inquiries from internal management and potential clients. Able to effectively manage strict deadlines, schedules and repetitive tasks with a positive, can-do attitude. Equipped with a broad knowledge of concepts and strategies to yield the best possible financial outcomes.
Takeda Pharmaceuticals Company completed its $62 billion acquisition of Shire PLC on January 7, 2019, becoming a global, values-based, R&D-driven biopharmaceutical leader.
Shire PLC completed its $32 billion merger with Baxalta Incorporated on June 3, 2016, creating a global market leader in rare diseases and other specialized disorders.
Baxalta Incorporated was spun from Baxter International Inc. into a public company effective July 1, 2015. Baxalta Incorporated is a global biopharmaceutical leader developing, manufacturing and commercializing therapies for orphan diseases and underserved conditions in hematology, oncology and immunology. Baxalta Incorporated was subsequently acquired by Shire PLC on June 3, 2016.
Solely responsible for corporate adherence to monthly, quarterly, semi-annual and annual domestic transaction tax compliance streams for sales/use tax, property tax, business license fees, federal branded prescription drug fee and federal medical device excise tax.
Authored and implemented executive Decision Document relative to outsourcing the preparation and filing of domestic sales/use tax returns. Partnered with Corporate Purchasing Team and Legal Team in drafting Request for Proposal, Statement of Work and Master Services Agreement relative to awarding the outsourcing contract.
Assist Senior Tax Counsel with domestic transaction tax planning strategies supporting corporate acquisitions, mergers and reorganizations.
Established compliance process for federal Medical Device Excise Tax and Federal Branded Prescription Drug Fee that successfully passed IRS and Corporate Audit scrutiny. Retained sole responsibility for existing Medical Device Excise Tax and Branded Prescription Drug Fee compliance of former Parent Company under reverse transition services agreement.
Create, arrange and present state/local SU tax seminars with field personnel (e.g. PSM Team, Plant Controllers, and Plant Finance) including preparation of taxability charts for use in making effective tax determinations at the field level.
Conduct vendor/supplier taxability review to ensure proper exemption certificates are on file for designated capital asset and expense purchase transactions.
Partner with Customer Service Team to secure valid customer sales tax exemption documentation prior to Day 1 sales.
A $38.96B Global medical products and services company with 75 years expertise in medical devices, pharmaceuticals and biotechnology.
[Tax Manager I (2006 – present); Finance Manager I (2003 – 2006); Sr. Tax Analyst (1999 – 2003)]
Resumes, and other information uploaded or provided by the user, are considered User Content governed by our Terms & Conditions. As such, it is not owned by us, and it is the user who retains ownership over such content.
Many factors go into creating a strong resume. Here are a few tweaks that could improve the score of this resume:
Job Titles Held: